Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma group ...
Hosted on MSN
Multiple line suspensions cause rush-hour Tube chaos
Commuters on the Tube are facing major disruption on Friday morning, following multiple points and signal failures. Earlier this morning, the entire Victoria line was suspended, while the Piccadilly ...
The Oklahoma City Thunder are off to a 27-5 start this season, sitting atop the NBA. The OKC Thunder got off to the best start in NBA history at 24-1 before hitting a rough patch over the last two ...
Unfortunately you've used all of your gifts this month. Your counter will reset on the first day of next month.
An inherent principle of publication is that others should be able to replicate and build upon the authors' published claims. A condition of publication in a Nature Portfolio journal is that authors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results